Ligand Pharmaceuticals Incorporated (LGND) vs Oruka Therapeutics, Inc. (ORKA)

• Ligand Pharmaceuticals Incorporated LGND 306.43 ▲ +2.48%
• Oruka Therapeutics, Inc. ORKA 102.68 ▲ +6.94%

Ligand Pharmaceuticals Incorporated and Oruka Therapeutics, Inc. are both Biotechnology companies. Ligand Pharmaceuticals Incorporated and Oruka Therapeutics, Inc. are of similar size ($6.4B and $6.0B). Oruka Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 116×. Ligand Pharmaceuticals Incorporated has the higher net margin (20.3% vs 0.00%) and the higher return on invested capital (1.27% vs −40.2%). Across the 14 metrics below, Ligand Pharmaceuticals Incorporated leads on 11 and Oruka Therapeutics, Inc. on 3.